|
Market Closed -
Nasdaq
16:00:01 2026-09-30 EDT
|
5-day change | 1st Jan Change | ||
| 60.00 USD | +0.22% |
|
-3.55% | +0.96% |
| Market Cap | 11.61B 10.23B 9.69B 8.75B 16.49B 1,114B 16.7B 116B 44.62B 569B 43.61B 42.66B 1,825B | P/E 2026 * |
21.8x | P/E 2027 * | 13.2x |
|---|---|---|---|---|---|
| Enterprise Value | 13.69B 12.05B 11.42B 10.31B 19.43B 1,312B 19.68B 137B 52.57B 671B 51.39B 50.27B 2,151B | EV / Sales 2026 * |
3.5x | EV / Sales 2027 * | 2.87x |
| Free-Float |
99.66% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BMRN | Delayed | |
CBOE
| BMRN | Real-time | |
|
Berne S.E.
| BM8 | End-of-day quote | |
|
London S.E.
| 0HNC | Delayed | |
|
Tradegate
| BM8 | Real-time | |
|
Mexican S.E.
| BMRN * | End-of-day quote | |
|
Deutsche Boerse AG
| BM8 | Delayed | |
|
Wiener Boerse
| BMRN | End-of-day quote | |
|
Börse Stuttgart
| BM8 | Delayed | |
|
Boerse Muenchen
| BM8 | Real-time | |
|
Borsa Italiana
| 1BMRN | End-of-day quote |
Last Transcript: BioMarin Pharmaceutical Inc.
| 1 day | +0.22% | ||
| 1 week | -3.55% | ||
| 1 month | -8.02% | ||
| 3 months | +4.86% | ||
| 6 months | +6.21% | ||
| Current year | +0.96% |
| 1 week | 58.74 |  | 61.5 |
| 1 month | 58.74 | | 67.7 |
| Current year | 49.26 | | 70.98 |
| 1 year | 49.26 | | 70.98 |
| 3 years | 49.26 | | 99.56 |
| 5 years | 49.26 | | 117.77 |
| 10 years | 49.26 | | 131.94 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alexander Hardy
CEO | Chief Executive Officer | 57 | 2023-11-30 |
Brian Mueller
DFI | Director of Finance/CFO | 52 | 2020-01-28 |
Arpit Davé
CTO | Chief Tech/Sci/R&D Officer | - | 2026-01-11 |
| Director | Title | Age | Since |
|---|---|---|---|
Willard Dere
BRD | Director/Board Member | 72 | 2016-07-17 |
Robert Hombach
BRD | Director/Board Member | 60 | 2017-09-28 |
| Director/Board Member | 69 | 2019-07-09 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/10/26 | Free | Director | 6,140 | 0.0032% | ||
| 9/2/26 | Sell | General Counsel | -17,557 | 0.0091% | ||
| 6/2/26 | Free | Director | 7,490 | 0.0039% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.22% | -3.55% | +10.78% | -32.19% | 11.59B | |
| -2.33% | +0.53% | +51.65% | +115.42% | 1,056B | |
| -1.06% | -1.65% | +42.78% | +69.98% | 645B | |
| -0.65% | -1.32% | +12.98% | +75.49% | 465B | |
| -2.66% | -1.87% | +73.13% | +41.15% | 368B | |
| -0.06% | -3.88% | +34.32% | +39.39% | 335B | |
| -0.79% | +2.01% | +19.82% | +27.79% | 275B | |
| -1.19% | -1.21% | +9.82% | +10.61% | 255B | |
| -0.50% | +3.80% | +49.37% | +56.84% | 229B | |
| -1.47% | -1.53% | +34.28% | +98.89% | 188B | |
| Average | -0.74% | -0.52% | +33.89% | +50.34% | 382.74B | |
| Weighted average by Cap. | -1.02% | -0.24% | +39.82% | +71.07% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.91B 3.44B 3.26B 2.94B 5.55B 375B 5.62B 39B 15.01B 192B 14.67B 14.35B 614B | 4.47B 3.94B 3.73B 3.37B 6.34B 428B 6.43B 44.61B 17.17B 219B 16.78B 16.41B 702B |
| Net income | 534M 470M 446M 402M 758M 51.2B 768M 5.33B 2.05B 26.18B 2.01B 1.96B 83.92B | 900M 793M 751M 678M 1.28B 86.33B 1.29B 8.99B 3.46B 44.14B 3.38B 3.31B 141B |
| Net Debt | 2.07B 1.82B 1.73B 1.56B 2.94B 199B 2.98B 20.68B 7.96B 102B 7.78B 7.61B 326B | 1.22B 1.07B 1.02B 919M 1.73B 117B 1.75B 12.18B 4.69B 59.79B 4.58B 4.48B 192B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-30 | US$60.00 | +0.22% | 1,797,889 |
| 26-09-29 | US$59.87 | +0.69% | 1,807,502 |
| 26-09-28 | US$59.46 | -1.33% | 2,357,963 |
| 26-09-25 | US$60.26 | -1.78% | 1,791,426 |
| 26-09-24 | US$61.35 | -1.38% | 1,659,446 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BMRN Stock
Select your edition
All financial news and data tailored to specific country editions
